Immunotherapy: A way to improve the therapeutic outcome of photodynamic therapy?

Photochemical and Photobiological Sciences

Volumn 7, Issue 9, 2008, Pages 1011-1017

  Kwitniewski, Mateusz ^a,b   Juzeniene, Asta ^b   Glosnicka, Renata ^c   Moan, Johan ^b,d  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c R and D Immunolab Company Ltd   (Poland)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

425 MONOCLONAL ANTIBODY; 5,6 DIMETHYLXANTHENONE 4 ACETIC ACID; ALUMINUM(III) PHTHALOCYANINE TETRASULFONATE; AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; BEVACIZUMAB; CARBOHYDRATE DERIVATIVE; CETUXIMAB; CHLORIN E6; D3 BINDING PROTEIN DERIVED MACROPHAGE ACTIVATING FACTOR; E 48; E 48 MONOCLONAL ANTIBODY; GAMMA INTERFERON; GAMMA INULIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HER 50; HER 50 MONOCLONAL ANTIBODY; HER 66; HER 66 MONOCLONAL ANTIBODY; IMIQUIMOD; MF 1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DC101; PHEOPHORBIDE A; PHOTOFRIN; PHOTOSENSITIZING AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; TUMOR VACCINE; U 36; U 36 MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; UNINDEXED DRUG; VEGF RECEPTOR 1 MONOCLONAL ANTIBODY; ZYMOSAN;

ADJUVANT THERAPY; ADOPTIVE TRANSFER; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BLADDER CARCINOMA; BREAST ADENOCARCINOMA; BREAST SARCOMA; CANCER THERAPY; CARBON DIOXIDE LASER; CLINICAL PRACTICE; COLON ADENOCARCINOMA; FIBROSARCOMA; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; IMMUNOTHERAPY; LUNG CARCINOMA; MELANOMA; NONHUMAN; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PHOTOIMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ANIMALIA;

EID: 50649124029     PISSN: 1474905X     EISSN: 14749092     Source Type: Journal    
DOI: 10.1039/b806710d     Document Type: Review

References (78)

1. I. J. Elenkov R. L. Wilder G. P. Chrousos E. S. Vizi The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system Pharmacol. Rev. 2000 52 595 638
2. D. Nowis T. Stoklosa M. Legat T. Issat M. Jakobisiak J. Golab The influence of photodynamic therapy on the immune response Photodiagn. Photodyn. Ther. 2005 2 283 298
3. A. P. Castano P. Mroz M. R. Hamblin Photodynamic therapy and anti-tumour immunity Nat. Rev. Cancer 2006 6 535 545
4. W. J. de Vree M. C. Essers J. F. Koster W. Sluiter Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors Cancer Res. 1997 57 2555 2558
5. J. Sun I. Cecic C. S. Parkins M. Korbelik Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours Photochem. Photobiol. Sci. 2002 1 690 695
6. D. Nowis M. Makowski T. Stoklosa M. Legat T. Issat J. Golab Direct tumor damage mechanisms of photodynamic therapy Acta Biochim. Pol. 2005 52 339 352
7. F. H. van Duijnhoven R. I. J. M. Aalbers J. P. Rovers O. T. Terpstra P. J. K. Kuppen The immunological consequences of photodynamic treatment of cancer, a literature review Immunobiology 2003 207 105 113
8. S. O. Gollnick S. S. Evans H. Baumann B. Owczarczak P. Maier L. Vaughan W. C. Wang E. Unger B. W. Henderson Role of cytokines in photodynamic therapy-induced local and systemic inflammation Br. J. Cancer 2003 88 1772 1779
9. M. B. Jameson B. C. Baguley P. Kestell L. Zhao J. W. Paxton P. I. Thompson S. Waller Pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (AS1404), a novel vascular disrupting agent, in phase I clinical trial Cancer Chemother. Pharmacol. 2007 59 681 687
10. D. A. Bellnier Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-alpha J. Photochem. Photobiol., B 1991 8 203 210
11. D. A. Bellnier S. O. Gollnick S. H. Camacho W. R. Greco R. T. Cheney Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors Cancer Res. 2003 63 7584 7590
12. S. Mocellin C. R. Rossi P. Pilati D. Nitti Tumor necrosis factor, cancer and anticancer therapy Cytokine Growth Factor Rev. 2005 16 35 53
13. L. M. Ching D. Goldsmith W. R. Joseph H. Körner J. D. Sedgwick B. C. Baguley Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice Cancer Res. 1999 59 3304 3307
14. W. R. Joseph Z. Cao K. G. Mountjoy E. S. Marshall B. C. Baguley L. M. Ching Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy Cancer Res. 1999 59 633 638
15. I. Cecic C. S. Parkins M. Korbelik Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors Photochem. Photobiol. 2001 74 712 720
16. W. J. de Vree M. C. Essers H. S. de Bruijn W. M. Star J. F. Koster W. Sluiter Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo Cancer Res. 1996 56 2908 2911
17. P. C. Kousis B. W. Henderson P. G. Maier S. O. Gollnick Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils Cancer Res. 2007 67 10501 10510
18. E. Fernandez-Varon L. Villamayor Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine Vet. J. 2007 174 33 41
19. G. Krosl M. Korbelik J. Krosl G. J. Dougherty Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor Cancer Res. 1996 56 3281 3286
20. J. Golab G. Wilczynski R. Zagozdzon T. Stoklosa A. Dabrowska J. Rybczynska M. Wasik E. Machaj T. Olda K. Kozar R. Kaminski A. Giermasz A. Czajka W. Lasek W. Feleszko M. Jakobisiak Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF Br. J. Cancer 2000 82 1485 1491
21. D. N. Sauder Immunomodulatory and pharmacologic properties of imiquimod J. Am. Acad. Dermatol. 2000 43 S6 11
22. X. Wang H. Wang M. Guo Z. Huang Combination of immunotherapy and photodynamic therapy in the treatment of Bowenoid papulosis Photodiagn. Photodynamic Ther. 2007 4 88 93
23. M. Korbelik P. D. Cooper Potentiation of photodynamic therapy of cancer by complement: the effect of gamma-inulin Br. J. Cancer 2007 96 67 72
24. K. Schroder P. J. Hertzog T. Ravasi D. A. Hume Interferon-gamma: an overview of signals, mechanisms and functions J. Leuk. Biol. 2004 75 163 189
25. M. Korbelik J. Sun I. Cecic K. Serrano Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors Photochem. Photobiol. Sci. 2004 3 812 816
26. R. Di Paola E. Mazzon C. Muia C. Crisafulli T. Genovese P. Di Bella E. Esposito M. Menegazzi R. Meli H. Suzuki S. Cuzzocrea Protective effect of Hypericum perforatum in zymosan-induced multiple organ dysfunction syndrome: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity Nitric Oxide 2007 16 118 130
27. A. Kunamneni T. T. Abdelghani P. Ellaiah Streptokinase-the drug of choice for thrombolytic therapy J. Thromb. Thrombolysis 2007 23 9 23
28. D. M. Klinman Immunotherapeutic uses of CpG oligodeoxynucleotides Nat. Rev. Immunol. 2004 4 249 258
29. J. A. Chabalgoity G. Dougan P. Mastroeni R. J. Aspinall Live bacteria as the basis for immunotherapies against cancer Expert Rev. Vaccines 2002 1 495 505
30. F. G. Perabo S. C. Muller Current and new strategies in immunotherapy for superficial bladder cancer Urology 2004 64 409 421
31. M. Korbelik I. Cecic Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment J. Photochem. Photobiol., B 1998 44 151 158
32. M. Korbelik J. Sun J. J. Posakony Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors Photochem. Photobiol. 2001 73 403 409
33. M. Szygula A. Pietrusa M. Adamek B. Wojciechowski A. Kawczyk-Krupka A. Cebula W. Duda A. Sieron Combined treatment of urinary bladder cancer with the use of photodynamic therapy (PDT) and subsequent BCG-therapy: a pilot study Photodiagn. Photodyn. Ther. 2004 1 241 246
34. M. D. Shelley H. Kynaston J. Court T. J. Wilt B. Coles K. Burgon M. D. Mason A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs. transurethral resection alone in Ta and T1 bladder cancer BJU Int. 2001 88 209 216
35. S. Krege G. Giani R. Meyer T. Otto H. Rubben F. Noll G. Jakse S. T. Muller H. J. Melchior L. Weissbach B. Terhorst P. Lenz P. Faul H. Sommerkamp B. Kopper R. Hautmann L. Knebel Keller F. Eisenberger W. Schaffner A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. Participating Clinics J. Urol. 1996 156 962 966
36. J. P. Meyer R. Persad D. A. Gillatt Use of bacille Calmette-Guerin in superficial bladder cancer Postgrad. Med. J. 2002 78 449 454
37. M. Uehara K. Sano Z. L. Wang J. Sekine H. Ikeda T. Inokuchi Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma Cancer Immunol. Immunother. 2000 49 401 409
38. M. Uehara T. Inokuchi Hyperthermic photodynamic therapy combined with topical administration of OK-432 in the mouse carcinoma Oral Oncol. 2003 39 184 189
39. G. Krosl M. Korbelik Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG) Cancer Lett. 1994 84 43 49
40. W. R. Chen M. Korbelik K. E. Bartels H. Liu J. Sun Nordquist RE, Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant Photochem. Photobiol. 2005 81 190 195
41. M. Korbelik V. R. Naraparaju N. Yamamoto Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer Br. J. Cancer 1997 75 202 207
42. N. Yamamoto H. Suyama N. Yamamoto N. Ushijima Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF) Int. J. Cancer 2008 122 461 467
43. O. Kisker S. Onizuka C. M. Becker M. Fannon E. Flynn R. D'Amato B. Zetter J. Folkman R. Ray N. Swamy S. Pirie-Shepherd Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice Neoplasia 2003 5 32 40
44. M. Korbelik J. Sun Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line Int. J. Cancer 2001 93 269 274
45. C. Staneloudi K. A. Smith R. Hudson N. Malatesti H. Savoie R. W. Boyle J. Greenman Development and characterization of novel photosensitizer: scFv conjugates for use in photodynamic therapy of cancer Immunology 2007 120 512 517
46. M. Bhatti G. Yahioglu L. R. Milgrom M. Garcia-Maya K. A. Chester M. P. Deonarain Targeted photodynamic therapy with multiply-loaded recombinant antibody fragments Int. J. Cancer 2008 122 1155 1163
47. M. D. Savellano B. W. Pogue P. J. Hoopes E. S. Vitetta K. D. Paulsen Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates Cancer Res. 2005 65 6371 6379
48. M. B. Vrouenraets G. W. Visser M. Stigter H. Oppelaar G. B. Snow G. A. van Dongen Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy Cancer Res. 2001 61 1970 1975
49. M. D. Savellano T. Hasan Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates Photochem. Photobiol. 2003 77 431 439
50. M. B. Vrouenraets G. W. Visser F. A. Stewart M. Stigter H. Oppelaar P. E. Postmus G. B. Snow G. A. van Dongen Development of meta- tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy Cancer Res. 1999 59 1505 1513
51. D. Mew C. K. Wat G. H. Towers J. G. Levy Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates J. Immunol. 1983 130 1473 1477
52. B. A. Goff J. Blake M. P. Bamberg T. Hasan Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model Br. J. Cancer 1996 74 1194 1198
53. M. Del Governatore M. R. Hamblin C. R. Shea I. Rizvi K. G. Molpus K. K. Tanabe T. Hasan Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate Cancer Res. 2000 60 4200 4205
54. N. S. Soukos M. R. Hamblin S. Keel R. L. Fabian T. F. Deutsch T. Hasan Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo Cancer Res. 2001 61 4490 4496
55. M. D. Savellano T. Hasan Photochemical targeting of epidermal growth factor receptor: a mechanistic study Clin. Cancer Res. 2005 11 1658 1668
56. A. Jalili M. Makowski T. Switaj D. Nowis G. M. Wilczynski E. Wilczek M. Chorazy-Massalska A. Radzikowska W. Maslinski L. Bialy J. Sienko A. Sieron M. Adamek G. Basak P. Mroz I. W. Krasnodebski M. Jakobisiak J. Golab Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells Clin. Cancer Res. 2004 10 4498 4508
57. H. Saji W. Song K. Furumoto H. Kato E. G. Engleman Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy Clin. Cancer Res. 2006 12 2568 2574
58. M. Korbelik G. J. Dougherty Photodynamic therapy-mediated immune response against subcutaneous mouse tumors Cancer Res. 1999 59 1941 1946
59. M. G. del Carmen I. Rizvi Y. Chang A. C. Moor E. Oliva M. Sherwood B. Pogue T. Hasan Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo J. Natl. Cancer Inst. 2005 97 1516 1524
60. B. J. Moeller R. A. Richardson M. W. Dewhirst Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment Cancer Metastasis Rev. 2007 26 241 248
61. L. Wyld M. W. Reed N. J. Brown The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro Br. J. Cancer 1998 77 1621 1627
62. D. A. Chan A. J. Giaccia Hypoxia, gene expression, and metastasis Cancer Metastasis Rev. 2007 26 333 339
63. D. Liao R. S. Johnson Hypoxia: a key regulator of angiogenesis in cancer Cancer Metastasis Rev. 2007 26 281 290
64. Q. Zhou M. Olivo K. Y. Lye S. Moore A. Sharma B. Chowbay Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models Cancer Chemother. Pharmacol. 2005 56 569 577
65. A. Ferrario K. F. von Tiehl N. Rucker M. A. Schwarz P. S. Gill C. J. Gomer Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma Cancer Res. 2000 60 4066 4069
66. A. Ferrario C. J. Gomer Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model J. Environ. Pathol. Toxicol. Oncol. 2006 25 251 259
67. R. Bhuvaneswari G. Y. Yuen S. K. Chee M. Olivo Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins Photochem. Photobiol. Sci. 2007 6 1275 1283
68. F. Jiang X. Zhang S. N. Kalkanis Z. Zhang H. Yang M. Katakowski X. Hong X. Zheng Z. Zhu M. Chopp Combination therapy with antiangiogenic treatment and photodynamic therapy for the nude mouse bearing U87 glioblastoma Photochem. Photobiol. 2008 84 128 137
69. R. K. Jain Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 2005 307 58 62
70. R. K. Jain D. G. Duda J. W. Clark J. S. Loeffler Lessons from phase III clinical trials on anti-VEGF therapy for cancer Nat. Clin. Pract. Oncol. 2006 3 24 40
71. S. O. Gollnick L. Vaughan B. W. Henderson Generation of effective antitumor vaccines using photodynamic therapy Cancer Res. 2002 62 1604 1608
72. M. Korbelik J. Sun Photodynamic therapy-generated vaccine for cancer therapy Cancer Immunol. Immunother. 2006 55 900 909
73. M. Korbelik B. Stott J. Sun Photodynamic therapy-generated vaccines: relevance of tumour cell death expression Br. J. Cancer 2007 97 1381 1387
74. J. E. Vance R. Steenbergen Metabolism and functions of phosphatidylserine Prog. Lipid Res. 2005 44 207 234
75. S. Mocellin S. Mandruzzato V. Bronte M. Lise D. Nitti Part I: Vaccines for solid tumours Lancet Oncol. 2004 5 681 689
76. J. Copier S. Ward A. Dalgleish Cell based cancer vaccines: regulatory and commercial development Vaccine 2007 25 2 B35 46
77. O. J. Finn Cancer vaccines: between the idea and the reality Nat. Rev. Immunol. 2003 3 630 641
78. N. L. Berinstein Enhancing cancer vaccines with immunomodulators Vaccine 2007 25 2 B72 88